貝瑞基因(000710.SZ):擬通過股權轉讓減資退出對信念醫藥的投資
格隆匯5月27日丨貝瑞基因(000710.SZ)公佈,公司於2020年5月27日召開第八屆董事會第二十九次會議,審議通過了《關於公司擬減資退出信念醫藥科技(蘇州)有限公司暨關聯交易的議案》、《關於公司簽署<股權轉讓協議>的議案》。公司擬通過股權轉讓減資退出對信念醫藥科技(蘇州)有限公司(以下簡稱“信念醫藥”)的投資,減資後公司將不再持有信念醫藥股權(以下簡稱“本次交易”)。
獨立董事已對本次交易發表了事前認可意見和同意的獨立意見,關聯董事ZHOUDAIXING(周代星)先生已迴避對本次交易的表決。
本次交易無需提交股東大會審,不構成《上市公司重大資產重組管理辦法》規定的重大資產重組、不構成借殼,無需經過有關部門批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.